STAT5A and acute lymphoblastic leukemia: Alternations involving CRLF2 and their impact on STAT5 can induce cytokine-independent survival and proliferation of early hematopoietic cells, potentially contributing to the development of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) [45].